LGVN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Longeveron LLC · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 0.70 USD
16.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -6.1% below the Trend Line and sits at 17.8% of its 52-week range. The latest completed week returned 16.9%, after a 1.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100. Near-term considerations: earnings are due in 10d.

Setup score 27 out of 100
Latest Close 0.70 USD 31 Jul 2026
1W Return 16.9% latest completed week
4W Return 1.6% short-term follow-through
12W Return -17.0% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 16.9% Latest completed week; four-week move 1.6%. Indicator stack 14/32 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 35.95% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 48/100 64 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -6.1% below the Trend Line and sits at 17.8% of its 52-week range. The latest completed week returned 16.9%, after a 1.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1112-week average 0.41

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.6% over four weeks, -17.0% over 12 weeks, and -57.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W16.9%
4W1.6%
12W-17.0%
26W25.3%
52W-57.1%
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.79Latest activity-pressure read.
Pressure change-48.0%Four-week change in activity pressure.
Leadership-13.27Latest relative-leadership reading.
RS change50.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength53/100Blend of value, momentum, and quality. Underlying universe rank 48; rank 1 is best.
Value51/100Relative valuation strength. Underlying universe rank 50; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth51/100Revenue and earnings growth. Underlying universe rank 50; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
15.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-452.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
65.1%
Gross profit retained from each unit of revenue.
Operating margin
-1844.5%
Operating profit retained from revenue.
Free-cash-flow margin
-1468.2%
Free cash flow generated from revenue.
Return on invested capital
-1654.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-45.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-97.0%
Net share repurchases relative to market value.
Shareholder yield
-97.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity7 / 5

7 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment48/100

Weighted news tone is neutral across 64 relevant articles.

2 positive · 54 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-59.9%Distance below the 52-week high.
13-week volatility11.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+101.3%Week of 13 Mar.
Worst week-20.7%Week of 15 May.
Latest week+16.9%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains1
Flat weeks0
Modest losses4
Sharp losses12
Recent vol11.1%13-week weekly-return volatility.
Base vol18.5%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew13.3% / -8.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

 Indicator analysis32/100

Latest 12-week confirmation: trend 8/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 35.95%

Next-week expectancy is negative with a 35.95% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 100 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment48/100

Weighted news tone is neutral across 64 relevant articles.

Longeveron Inc (LGVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders7 / 5

7 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.70 USD16.9%0.75 USD4.47 USD-0.79-13.271.6MOff
24 Jul 20260.60 USD-3.5%0.74 USD4.69 USD-0.81-27.71756.1KOff
17 Jul 20260.62 USD-7.9%0.74 USD4.89 USD-0.72-28.611.1MOff
10 Jul 20260.68 USD-2.2%0.74 USD5.11 USD-0.64-27.771.5MOff
3 Jul 20260.69 USD-3.5%0.74 USD5.33 USD-0.53-26.571.8MOn
26 Jun 20260.72 USD-12.8%0.73 USD5.53 USD-0.46-24.791.3MOn
19 Jun 20260.82 USD4.8%0.73 USD5.74 USD-0.34-19.29799.6KOn
12 Jun 20260.78 USD7.2%0.73 USD5.97 USD-0.18-22.21724.5KOn
5 Jun 20260.73 USD-5.5%0.72 USD6.23 USD-0.09-27.161.3MOn
29 May 20260.77 USD-5.9%0.72 USD6.44 USD0.13-27.691.2MOn
22 May 20260.82 USD22.3%0.72 USD6.64 USD0.33-22.362.5MOn
15 May 20260.67 USD-20.7%0.73 USD6.84 USD0.56-37.013.2MOn
8 May 20260.85 USD-0.7%0.73 USD7.04 USD0.86-22.631.6MOn
1 May 20260.85 USD-9.5%0.73 USD7.25 USD1.05-19.391.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.